Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISATRACURIUM for Neuromuscular blocking therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 95 adverse event reports in the FDA FAERS database where CISATRACURIUM was used for Neuromuscular blocking therapy.

Most Reported Side Effects for CISATRACURIUM

Side Effect Reports % Deaths Hosp.
Anaphylactic shock 221 12.9% 14 48
Hypotension 113 6.6% 16 51
Off label use 109 6.3% 22 53
Anaphylactic reaction 107 6.2% 3 40
Anaesthetic complication neurological 89 5.2% 0 1
Drug ineffective 71 4.1% 6 26
Cardiac arrest 67 3.9% 28 21
Drug reaction with eosinophilia and systemic symptoms 67 3.9% 0 58
Toxic epidermal necrolysis 63 3.7% 45 58
Hyperthermia malignant 60 3.5% 14 29
Erythema 47 2.7% 0 24
Rhabdomyolysis 47 2.7% 12 14
Tachycardia 44 2.6% 6 19
Bronchospasm 41 2.4% 2 11
Hypoxia 40 2.3% 28 30

Other Indications for CISATRACURIUM

Product used for unknown indication (235) General anaesthesia (224) Anaesthesia (207) Induction of anaesthesia (179) Sedation (123) Induction and maintenance of anaesthesia (93) Endotracheal intubation (84) Sedative therapy (47) Neuromuscular blockade (45) Muscle relaxant therapy (31)

Other Drugs Used for Neuromuscular blocking therapy

ROCURONIUM (383) INCOBOTULINUMTOXINA (70) ATRACURIUM (61) SUCCINYLCHOLINE (37) VECURONIUM (18) NIMESULIDE (8) ESLAX (6) SUGAMMADEX (5)

Related Pages

CISATRACURIUM Full Profile All Neuromuscular blocking therapy Drugs CISATRACURIUM Demographics CISATRACURIUM Timeline